FIELD: medicine; pharmaceuticals.
SUBSTANCE: invention relates to pharmaceutics and medicine and represents an antioxidant composition suitable for oral administration in the therapy of the inflammatory process in the lungs, characterized by that it contains echinochrome, ascorbic acid, α-tocopherol acetate, microcrystalline cellulose (MCC), colloidal silicon dioxide (Aerosil) and magnesium stearate, wherein components in the composition are in a certain ratio, wt %.
EFFECT: invention provides a bioavailable, completely gastric soluble antioxidant composition suitable for oral administration, as well as provides a wider range of products for therapy of inflammatory process in the lungs.
1 cl, 3 ex, 2 tbl
Title | Year | Author | Number |
---|---|---|---|
ANTIVIRAL COMPOSITION | 2018 |
|
RU2697886C1 |
NEW DOSAGE FORM OF ECHINOCHROME A, A METHOD OF ITS PREPARATION AND USE | 2022 |
|
RU2800382C1 |
CORRECTIVE COMPOSITION FOR PATHOLOGIC CARBOHYDRATE, LIPID DISBOLISM AND ANTIOXIDANT ORGANISM STATE INVOLVEMENT | 2008 |
|
RU2360683C1 |
DIETARY SUPPLEMENT AND METHOD FOR ITS PRODUCTION | 2023 |
|
RU2825783C1 |
DIETARY SUPPLEMENT AND METHOD OF ITS PRODUCTION | 2007 |
|
RU2340216C1 |
COMPOSITION FOR INTERNAL USE FOR HORMONE SKIN AGING CORRECTION | 2012 |
|
RU2527344C2 |
PREPARATION "GISTOKHROM" FOR TREATMENT OF EYE RETINA AND CORNEA INFLAMMATORY SICKNESSES | 1998 |
|
RU2134107C1 |
THERAPEUTIC NUTRIENT COMPOSITION | 2014 |
|
RU2571815C1 |
COMPOSITION FOR STABILIZATION OF LIPIDS | 1999 |
|
RU2157829C1 |
ANTIVIRAL AGENT AGAINST HERPES SIMPLEX VIRUS TYPE 1 | 2022 |
|
RU2782935C1 |
Authors
Dates
2019-04-15—Published
2018-08-06—Filed